Assal Frédéric, Alarcón Maricela, Solomon Esther C, Masterman Donna, Geschwind Daniel H, Cummings Jeffrey L
Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, Calif., USA.
Arch Neurol. 2004 Aug;61(8):1249-53. doi: 10.1001/archneur.61.8.1249.
Serotonin has been linked to neuropsychiatric symptoms in Alzheimer disease, mainly agitation/aggression, depression, and psychosis. Neuropsychiatric symptoms have been associated with polymorphisms of the promoter region (5-HTTPR ) and intron 2 of the serotonin transporter gene (5-HTTVNTR) or the 5-HT2A and 5-HT2C receptor genes in some but not all studies.
To examine the association of the serotonin promoter, transporter, and receptor genes with neuropsychiatric symptoms in patients with Alzheimer disease.
The sample included 96 patients with Alzheimer disease from the outpatient clinic of the University of California Los Angeles Alzheimer's Disease Research Center, Los Angeles. The Neuropsychiatric Inventory was used to measure neuropsychiatric symptoms, and blood samples were available for genetic analysis. Based on the literature, we hypothesized that the 5-HT2A and 5-HT2C receptor polymorphisms would be associated with agitation/aggression and psychosis and the 5-HTTPR or 5-HTTVNTR polymorphisms, with agitation/aggression or depression and anxiety. One-way analyses of variance were performed with age, ethnicity, sex, or education as covariates.
The 102T genotype of the 5-HT2A receptor was significantly associated with delusions (P =.045) and agitation/aggression (P =.002). We did not replicate previous associations of the 5-HT2C receptor polymorphism with psychosis or of the 5-HTTPR polymorphism with agitation/aggression, psychosis, or depression. We did not find any associations with the 5-HTTVNTR polymorphism and agitation/aggression, depression, or anxiety.
The 5-HT2A receptor polymorphism may contribute to the expression of psychosis and agitation/aggression in patients with Alzheimer disease. Absence of other positive associations may be due to the relatively small sample size and/or potentially small effect size of the polymorphisms and requires further study.
血清素与阿尔茨海默病的神经精神症状有关,主要是激越/攻击行为、抑郁和精神病。在一些但并非所有研究中,神经精神症状与血清素转运体基因(5-HTTVNTR)启动子区域(5-HTTPR)和内含子2或5-HT2A和5-HT2C受体基因的多态性有关。
研究血清素启动子、转运体和受体基因与阿尔茨海默病患者神经精神症状之间的关联。
样本包括来自洛杉矶加利福尼亚大学洛杉矶分校阿尔茨海默病研究中心门诊的96例阿尔茨海默病患者。使用神经精神科问卷来测量神经精神症状,并采集血样进行基因分析。基于文献,我们假设5-HT2A和5-HT2C受体多态性与激越/攻击行为和精神病有关,而5-HTTPR或5-HTTVNTR多态性与激越/攻击行为、抑郁和焦虑有关。以年龄、种族、性别或教育程度作为协变量进行单因素方差分析。
5-HT2A受体的102T基因型与妄想(P = 0.045)和激越/攻击行为(P = 0.002)显著相关。我们没有重复先前关于5-HT2C受体多态性与精神病或5-HTTPR多态性与激越/攻击行为、精神病或抑郁之间的关联。我们没有发现5-HTTVNTR多态性与激越/攻击行为、抑郁或焦虑之间存在任何关联。结论:5-HT2A受体多态性可能促成阿尔茨海默病患者精神病和激越/攻击行为的表达。其他阳性关联的缺失可能是由于样本量相对较小和/或多态性的效应量可能较小,需要进一步研究。